Select a Region North America


Mike Scott



Consulting (Strategy Management & Regulatory), Market Access, Oncology, Specialty & Direct-to-Patient Distribution

Mike has over 25 years of experience in marketing and sales, market access, channel design, sales training and sales management, and has been involved in over 25 product launches in sales, marketing or consulting roles. He has held leadership positions with global companies such as Johnson & Johnson, UCB and United BioSource Corporation.

With experience in design and execution of access strategies, Mike has launched more than 60 patient and provider support programs encompassing diverse issues such as reimbursement, channel design, patient assistance programs, copay programs, call centers, sites of care and clinical trial support. His core areas of experience include products with complex characteristics such high cost oral, IV, SC and IM therapies.

Mike earned a BA degree in Marketing from Northeast Louisiana University.

Articles by Mike Scott

Repairing the Patient Journey: How Pharma Can Fix the Obvious – and Not So Obvious – Breaking Points of Nonadherence

The challenges facing the pharmaceutical and healthcare industries to achieve and maintain proper adherence among patients are vast and wide. Alarming statistics reveal how extensive the issue truly is, impacting nearly 50% of patients with chronic illnesses and resulting in substantial healthcare costs and avoidable hospitalizations and deaths. In this latest article from industry experts […]

Understanding the Inflation Reduction Act: Drug Price Negotiation

In this second of a series, we explore the details known so far about Medicare drug price negotiation resulting from the implementation of the Inflation Reduction Act. The Centers for Medicare and Medicaid Services (CMS) has gradually been releasing guidance for manufacturers on the negotiation process. As this information has been released, Merck and the […]

Understanding the Inflation Reduction Act: Inflation Rebates

Prescription drug manufacturers routinely implement price increases for a variety of reasons that support their business. With the passage of the Inflation Reduction Act late in 2022, Congress added a twist to these price increases. One provision of the Act, also known as the IRA, implements rebates from pharmaceutical companies to Medicare for price increases […]

How Specialty Pharmacies Can Elevate Your Channel and Distribution Strategy for HCP-administered Buy & Bill Products

A successful channel and distribution strategy for Buy & Bill (B&B) products should be centered around the partners you sell to and through. That means considering any third-party logistics (3PL) providers, specialty distributors (SD) and specialty pharmacies (SP) who will touch your product between the manufacturing/packaging site and patient administration. Taking a holistic view of […]

Commercialization Strategies in Oncology — The Right Partner Can Reduce Risk and Boost Rewards

Whether you are an emerging company launching your first product or an established company expanding your portfolio, a number of parallel initiatives must be developed and executed to help your therapy get out of the shadow zone and into the limelight. Working closely with the right partner can help your company to differentiate the therapy, […]

Competitive Benchmarking In Trade – Answering The Who, What, Why and When

Last month our colleague Derek Cothran addressed the importance of using secondary research to benchmark your Patient Support Program (PSP) against obvious and not-so-obvious competitors. We’d like to continue a discussion around competitive benchmarking in this month’s blog, but this time focused on how it can be used to optimize a channel or distribution strategy […]

Are You Benchmarking Your PSP Against Others? If So, Who and What Are You Comparing It Against?

Many of our clients are looking for ways to ensure their Patient Support Program (PSP) is not only serving their patient and provider populations well but that it is doing so in a fiscally responsible way. Additionally, they are seeking validation that their PSP is at least at parity or superior to the competitor products’ […]

Are You Tracking the Performance and Satisfaction Ratings of Your Patient Services?

The types of services patients need for support change and fluctuate over time, particularly as a product moves through its lifecycle. The patient services necessary to drive access, affordability and adherence to your product in the launch phase can be markedly different from the patient services that accomplish the same goals at later stages of […]

Five Things You Should Do to Ensure Your PSP Is Ready for Launch Before Your Brand Is

Your brand is preparing for launch, and it’s time to develop a strategy for your Patient Services Program (PSP). Even if you already have one or more PSPs in place for your company’s other brands, it is important to make sure you don’t incorporate a one-size-fits-all approach for your PSP. In order to develop a […]

Interested in scheduling a meeting or speaking event?